Thus, DONSON was found to be a robust biomarker for risk stratification in clear cell renal cell carcinoma (ccRCC), and in vitro, DONSON was linked to a malignant phenotype in ccRCC cell culture models [7,8]. This evidence concerns the gene DONSON and nonpapillary renal cell carcinoma.